logologo
Search anything
Ctrl+K
arrow
WhatsApp Icon

Emami buys IncNut stake to scale Vedix, SkinKraft brands

EMAMILTD

Emami Ltd

EMAMILTD

Ask AI

Ask AI

Deal announcement and what is being acquired

Kolkata-based Emami said on Thursday it will acquire a 60% stake in IncNut Digital Pvt Ltd, the parent company of direct-to-consumer personalised beauty brands Vedix and SkinKraft. The acquisition is positioned as a step to strengthen Emami’s presence in beauty and personal care, especially in digital-first and premium categories. IncNut is known for building an online-first model around customised skincare and haircare products. Emami said the transaction will be executed through a Share Subscription and Purchase Agreement (SSPA). After completion, IncNut Digital and its wholly owned subsidiary, IncNut Lifestyle Retail Private Limited, will become subsidiaries of Emami.

Valuation, payment structure, and earn-out mechanics

Emami said it will invest up to ₹321 crore in cash for the 60% stake. The deal includes performance-linked adjustments over the next 24 months, indicating an earn-out structure tied to operating outcomes. The company also disclosed it intends to purchase the remaining 40% stake in two phases over the next four-and-a-half years. The valuation for these later tranches will be linked to IncNut’s future performance, as per Emami’s exchange filing. This structure spreads the final pricing over multiple years and ties it to the business trajectory of the acquired brands.

Timeline and closing conditions

Emami informed stock exchanges on May 7, 2026 that its Board of Directors approved the acquisition. The company said the transaction is expected to be completed within 30 days, subject to customary closing conditions. The phased acquisition of the remaining stake will play out over the next 4.5 years in two tranches. Emami’s disclosure also stated that the proposed acquisition does not qualify as a related party transaction. It added that none of its promoters, promoter group entities, or group companies have any interest in the target company.

Market reaction: Emami shares move higher

After the announcement, Emami’s shares were trading 1.19% higher at ₹457.65 on the BSE at 11:59 am. The stock move reflects an immediate positive reaction to the deal communication, though it does not indicate any longer-term outcome. The acquisition places Emami more firmly in the fast-expanding direct-to-consumer beauty segment. In this category, consumer preference is increasingly shifting towards products tailored to specific needs rather than standardised formulations.

IncNut’s business: Vedix and SkinKraft explained

IncNut was among the early entrants in India’s personalised beauty and wellness space. Through Vedix and SkinKraft, it built a customised offering designed around individual customer profiles and concerns. Emami said Vedix blends Ayurvedic principles with consumer data to create personalised formulations based on lifestyle and body type. SkinKraft, in contrast, focuses on dermatologist-backed skincare solutions for specific skin and hair issues using clinically tested ingredients. The combination gives IncNut exposure to both Ayurveda-led and dermatology-led personalisation, built largely through a digital-first distribution model.

IncNut financial snapshot: turnover has declined

IncNut Digital was incorporated in Telangana in 2011. The company reported consolidated turnover of ₹175.1 crore in FY2024-25, compared with ₹196.5 crore in FY2023-24 and ₹231.9 crore in FY2022-23. Emami’s disclosure, as cited in the provided information, did not include IncNut’s FY2025-26 sales figure. Separately, it was noted that the target company’s sales over the last three fiscals have declined year-on-year. These numbers set the context for why the final valuation for the balance stake is linked to future performance.

Why Emami is leaning into D2C beauty

Emami said the acquisition gives it a stronger foothold in the rapidly expanding direct-to-consumer beauty segment. Harsha Vardhan Agarwal, Vice Chairman and Managing Director, said the investment is a strategic step to strengthen Emami’s presence in the high-growth beauty and personal care segment. He also said that while the broader beauty and personal care market is expanding, meaningful differentiation remains limited, with only a few players offering deeply personalised, outcome-driven solutions. Agarwal added that as consumer preferences shift towards efficacy and customisation, Emami sees personalised beauty as a long-term growth opportunity in India and globally.

Fit with Emami’s existing beauty portfolio

Emami already owns The Man Company and Brillare, both acquired in the beauty and personal care segment. The company said it will partner with the founders and management team of IncNut Digital to scale Vedix and SkinKraft. This approach suggests Emami aims to keep execution continuity while adding distribution and operating support from a larger FMCG platform. The deal also aligns with a broader pattern of established consumer companies buying digital-first brands to strengthen premium and online capabilities.

What the founders said about the partnership

IncNut Founder and CEO Chaitanya Nallan described the partnership as a key turning point for both SkinKraft and Vedix. He said that by leveraging Emami’s consumer expertise and execution capabilities, IncNut plans to fast-track innovation and scale its reach. The statements from both sides emphasise scaling and product innovation rather than immediate integration into legacy distribution. The next operational milestones will likely be linked to the performance metrics that influence the earn-out adjustments over 24 months and the valuation of the remaining stake over the next 4.5 years.

Key numbers at a glance

ItemDetail
Stake Emami to acquire now60% (fully diluted basis)
ConsiderationUp to ₹321 crore (all-cash)
Performance-linked adjustment period24 months
Remaining stake planBalance 40% in two tranches over 4.5 years
Emami share price reactionUp 1.19% to ₹457.65 (BSE, 11:59 am)
IncNut consolidated turnoverFY2024-25: ₹175.1 crore; FY2023-24: ₹196.5 crore; FY2022-23: ₹231.9 crore

Why this matters for investors and the sector

For Emami, the transaction adds exposure to personalisation-led beauty in a segment where brand building is often driven by digital acquisition, retention, and repeat purchase dynamics. The earn-out structure and performance-linked pricing for the remaining stake suggest Emami is calibrating risk to future execution. For the D2C beauty ecosystem, the deal reinforces the role of strategic acquisitions as an exit or scale pathway, particularly for brands built online-first. Over the near term, the market will watch for the transaction closure within the stated timeline and any subsequent disclosures on IncNut’s operating performance that may affect the next phases of acquisition.

Conclusion

Emami’s decision to buy 60% of IncNut Digital for up to ₹321 crore places Vedix and SkinKraft under a larger FMCG umbrella while keeping future payouts linked to business performance. The transaction is expected to close within 30 days, subject to customary conditions, with the balance stake to be acquired over 4.5 years in two tranches. The next set of updates is likely to come through exchange disclosures around completion, subsidiary status, and any performance-linked adjustments over the coming 24 months.

Frequently Asked Questions

Emami will acquire a 60% stake in IncNut Digital on a fully diluted basis, making IncNut Digital a subsidiary after completion.
Emami will invest up to ₹321 crore in an all-cash deal, with performance-linked adjustments over the next 24 months.
Yes. Emami plans to acquire the remaining 40% stake over the next four-and-a-half years in two tranches, with valuation linked to future performance.
Vedix offers personalised formulations combining Ayurvedic principles with consumer data, while SkinKraft focuses on dermatologist-backed skincare and haircare using clinically tested ingredients.
IncNut reported consolidated turnover of ₹175.1 crore in FY2024-25, versus ₹196.5 crore in FY2023-24 and ₹231.9 crore in FY2022-23.

Did your stocks survive the war?

See what broke. See what stood.

Live Q4 Earnings Tracker